Chinese (SSE) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 24, 2026

Discover Chinese Pharmaceuticals & Biotech Growth Stocks that are on the SSE. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

320 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
688217	CN¥32.59	2.5%	66.1%	CN¥1.8b	n/a	9.4	134.7%	1.0%
300204	CN¥28.39	-0.5%	323.7%	CN¥13.6b	CN¥55.24	55.5	127.2%	0%
688266	CN¥87.80	-6.7%	32.9%	CN¥23.2b	CN¥140.00	31.3	124.8%	n/a
688114	CN¥70.65	5.1%	75.4%	CN¥29.1b	CN¥81.93	9.7	124.2%	0%
300676	CN¥53.71	1.3%	37.9%	CN¥20.6b	CN¥57.72	5.6	112.2%	0%
603108	CN¥17.72	-2.2%	9.6%	CN¥10.7b	CN¥20.00	1.4	110.6%	0.2%
688276	CN¥20.61	2.3%	-8.6%	CN¥8.5b	CN¥32.00	12.6	110.4%	0.8%
301207	CN¥19.45	1.6%	14.2%	CN¥11.6b	CN¥30.00	164.2	109.7%	3.1%
688192	CN¥60.00	-11.6%	44.2%	CN¥27.8b	CN¥94.88	45.8	102.3%	n/a
300122	CN¥17.28	-8.7%	-28.9%	CN¥41.4b	CN¥24.78	3.8	102.1%	1.2%
300723	CN¥36.40	-3.9%	130.8%	CN¥16.3b	CN¥35.88	16.0	101.5%	0%
300404	CN¥10.99	-0.2%	31.6%	CN¥4.2b	n/a	567.9	99.1%	0.1%
301096	CN¥57.85	-2.6%	69.0%	CN¥6.3b	n/a	10.6	90.9%	0%
603520	CN¥10.79	6.4%	30.0%	CN¥4.7b	CN¥14.23	2.0	90.4%	1.9%
300363	CN¥25.95	-6.9%	62.5%	CN¥14.0b	CN¥30.00	4.1	89.4%	0%
688520	CN¥46.33	-1.6%	26.5%	CN¥20.6b	CN¥49.00	10.9	83.0%	n/a
688062	CN¥40.30	-6.8%	156.9%	CN¥16.1b	n/a	25.8	82.4%	n/a
688105	CN¥22.00	0.7%	7.8%	CN¥8.8b	CN¥28.13	6.5	80.6%	1.4%
300765	CN¥39.47	-1.3%	38.6%	CN¥55.0b	CN¥57.80	26.2	80.5%	0.05%
2728	CN¥11.99	4.1%	49.7%	CN¥6.0b	n/a	75.1	73.3%	0.4%
688443	CN¥29.24	-4.6%	15.8%	CN¥10.7b	CN¥40.00	47.6	72.9%	n/a
300601	CN¥15.97	2.2%	9.9%	CN¥17.8b	CN¥19.80	6.6	69.7%	0.6%
300463	CN¥11.83	1.8%	-3.0%	CN¥7.2b	CN¥14.90	3.2	64.3%	0.9%
688506	CN¥290.61	-7.8%	49.2%	CN¥120.0b	n/a	53.9	62.8%	0%

Page 1 of 14